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It  has  recently  been  demonstrated  that  serum  lipoproteins  can  regulate  several 
aspects of lymphocyte function and metabolism. Chisari and Edgington (1) reported that 
a certain subfraction of serum low density lipoproteins (LDL)  1 from patients with viral 
hepatitis selectively inhibited the erythrocyte (E) rosette function of human T lympho- 
cytes.  In examining this  rosette  inhibitory factor further,  Curtiss  and  Edgington (2) 
observed that  a  subspecies  of LDL,  apparently different from normal human  serum, 
potently inhibited the proliferation of lymphocytes stimulated by phytohemagglutinin 
(PHA), pokeweed mitogen, and allogeneic cells.  More recently, inhibition of lymphocyte 
stimulation  by lectins  and  by  allogeneic cells  has  been  observed  with  plasma  from 
patients  with  type IV or type  V  hyperlipoproteinemia  (3). The  inhibitory effect was 
found to reside  in the chylomicron and very low density lipoprotein  (VLDL)  fractions 
obtained  from these  plasma  samples.  Human  lymphocytes have  also  been  shown to 
have high affinity cell surface receptors for LDL that vary in number depending upon 
the concentration of LDL to which the cells are exposed, and that play an important role 
in the regulation of cholesterol and lipoprotein metabolism by the cells (4). 
None of the previous studies  has  systematically compared the  effects of all 
the different classes of normal lipoproteins on stimulated lymphocytes. We now 
report  the  comparative  effects  of  each  of  the  lipoprotein  classes,  VLDL, 
intermediate  density  lipoproteins  (IDL),  LDL,  and  high  density  lipoproteins 
(HDL),  on  lymphocytes  stimulated  by  PHA,  concanavalin  A  (Con  A),  and 
allogeneic cells in lipoprotein-deficient plasma (LPDP). 
Materials  and Methods 
Lipoprotein  Preparation.  Lipoproteins were isolated from fresh plasma  and separated  from 
whole blood collected in 0.1% EDTA  as an anticoagulant  from normal healthy subjects. Lipopro- 
teins  were separated  by sequential  ultracentrifugation  of plasma  at densities  of 1.006, 1.019, 
1.063, and 1.21, according to standard  techniques  (5); the lipoprotein fractionations were carried 
out in a Beckman model L2-65B ultracentrifuge  utilizing  the Beckman 50 Ti rotor  (Beckman 
Instruments,  Inc., Fullerton,  Calif.) at 40,000 rpm and 4°C for 16-40 h. The resulting lipoprotein 
fractions included the VLDL (d < 1.006 g/ml), IDL (d = 1.006-1.019), LDL (d = 1.019-1.063) and 
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HDL (d =  1.063-1.21), and the LPDP fraction (d >  1.21).  The isolated lipoproteins and the LPDP 
were  dialyzed  extensively  against phosphate-buffered  saline  (pH  7.4)  for  48  h  at  4°C.  After 
dialysis,  the  lipoprotein  preparations  were  analyzed  for  protein  concentration by  either  the 
method of Lowry et al.  (6),  or that of Schaffner and Weissman (7); the latter method was used if 
the lipid content of the preparations (VLDL and IDL) interfered with the method of Lowry et al. 
The various preparations were also assayed for their concentrations of cholesterol and triglyceride 
with a  Technicon AutoAnalyzer I  (Technicon Instruments Corp.,  Tarrytown,  N.  Y.)  using the 
method N-24a for cholesterol (8) and a modification (9) of the Kessler and Lederer technique (10) 
for triglycerides.  The relative proportions of protein  and of each lipid were found to be in the 
expected range (5,  11,  12) for each different lipoprotein fraction. 
After the protein  and lipid  assays,  the  preparations were  dialyzed  against the RPMI  1640 
culture medium (see below) for 24 h with several changes of dialysis solution. The volumes were 
then adjusted with culture medium to the desired protein concentrations for addition to the cell 
culture mixtures. 
Lymphocyte  Isolation.  Peripheral blood lymphocytes were isolated from heparinized venous 
blood by a  modification of the method of B6yum  (13).  40-50-m1 samples of blood were obtained 
from normal donors, and the erythrocytes were allowed to sediment by gravity at 37°C for 1-2 h. 
The resulting plasma-leukocyte mixture was collected and gently mixed with an equal volume of 
sterile  isotonic  saline  solution.  Two volumes  of  the  saline-plasma-leukocyte  mixture  were layered 
over one volume of Ficoll-Conray solution (the  latter  consisting of 10 ml of 33.4% Conray 
(meglumine iothalamate, from Mallinckrodt Inc.,  St. Louis,  Mo.),  prepared from a 60% aqueous 
solution,  plus  24 ml of  9% Ficoll  (Pharmacia Fine Chemicals, Piscataway, N. J.).  The tubes were 
centrifuged  at 1,500  rpm for  30 inin  at 4°C.  The cells,  collected  from the interface,  were washed 
three  times  with  RPMI 1640 (Grand  Island  Biological  Co.,  Grand  Island,  N. Y.)  and  supplemented 
with 50 U/ml penicillin,  50 /zg/ml streptomycin, and 2 mM  L-glutamine. The cells,  usually 
comprising 285% lymphocytes and 15% monocytes, were subsequently cultured in this  medium 
with the addition  of  10% (final  volume) autologous plasma, 10% type AB plasma heated to 56°C 
for 30 min, or 20-25% LPDP. This amount of  LPDP provided plasma protein  equivalent to that 
contained in 10% whole plasma because of the dilution  occurring during the ultracentrifugal 
isolation  of  LPDP. 
Mitogen  Stimulation.  The effects  of the addition of a mitogen alone, or together with 
lipoproteins,  were assessed by determining the extent to which there was stimulation of  the 
incorporation  of  [3H]thymidine into  DNA  of  cultured  cells.  0.25-mi  triplicate  cultures  containing 
1 or 2 × 105 lymphocytes per well were placed in microtiter  plates  (IS FB 96, Linbro Chemical 
Co.,  New Haven, Conn.) and incubated at  37°C in  an atmosphere  of  5% CO2:95% air  for  periods  of 
3-5 days. At the start  of the incubation, an optimal amount of mitogen (see  below), with or 
without lipoproteins,  was added to each well.  At 15-16 h before  the cells  were harvested, 1 ~Ci 
[methyl-3H]thymidine  (6.7  Ci/mmol, from New England Nuclear, Boston, Mass.) was added per 
well. The microtiter  cultures were harvested and washed extensively with isotonic  saline  on 
glass  fiber  filters  (grade 934 AH, H. Reeve Angel &  Co.,  Inc.,  Clifton,  N. J.),  using a Mash II 
Harvester (Microbiological  Associates,  Bethesda, Md.) (14).  The filters  were dried and placed in 
12 ml of  Instabray (Yorktown Research Inc.,  Hackensack, N. J.).  Radioassay for  3H was carried 
out in a model 3320 liquid  scintillation  spectrometer (Packard Instrument Co.,  Inc.,  Downers 
Grove, Ill.).  The concentrations  of  the various lipoprotein  preparations and the other conditions 
employed in the different  experiments are indicated  in Results.  The results  were expressed,  for 
each set of  triplicate  samples, as the mean _+ SEM  of  the counts per minute of [~H]thymidine 
incorporated into  DNA  per culture.  Cell  viability  as determined by trypan blue dye exclusion 
was 82-88% at  the end of  culture. 
The mitogens used included phytohemagglutinin-P (PHA-P, from Difco  Laboratories,  Detroit, 
Mich.) and Con A (from Calbiochem, San Diego, Calif.).  Dose-response curves with PHA-P and 
Con A were performed in a previous study,  and lymphocytes from all  normal individuals  tested 
responded  strongly  to  the doses  of  each  mitogen employed in  the present experiments (15).  When 
used, Con A was added to a final  concentration of  5 ~g/ml in the culture mixture. PHA-P was 
added from a pretested  and standardized stock  solution  and when used,  the cultures  contained 
either i or 5 ~l of  the stock  PHA-P solution  per ml of  culture  mixture. 
Allogeneic  Cell  Stimulation.  Unidirectional  mixed  lymphocyte  cultures  were  prepared  by 
first incubating the stimulating lymphocytes at 2  x  l0  g cells/ml for 1 h  at 37°C  with 25 t~g/ml JANE  H.  MORSE,  LARRY  D.  WITTE,  AND  DEWITT  S.  GOODMAN  1793 
mitomycin-C (Sigma Chemical Co.,  St. Louis,  Mo.),  and then washing them three times with 
large volumes of  RPMI 1640.  Preliminary cultures  were performed with unrelated donors, and 
the most reactive  ratios  of  stimulater to resPonder cells  (1:1  or 2:1;  see Results,  e.g. 2 x 105 of 
each kind  of  cells  per  0.25  ml culture  mixture)  were used  in  the  experiments. Bidirectional  mixed 
lymphocyte cultures were performed with an equal number of lymphocytes from each donor, 
usually 2 x 105 cells  from each donor per 0.25  ml of  culture mixture. Cultures were carried  out 
under the conditions  described above; lipoproteins  were added at the start  of  the culture in the 
amounts indicated in Results. After 3-5 days, the cultures were assayed for the extent of 
stimulation  of  the  incorporation  of  [3H]thymidine into  DNA by  the'procedures  described  above. 
Results 
Effects of Lipoproteins on Allogeneic Cell Stimulation.  A  series of experi- 
ments  was  first  conducted  to  compare  the  effects of three  classes  of normal 
plasma lipoproteins (VLDL, LDL, and HDL, isolated by sequential flotation at 
densities of 1.006,  1.063,  and 1.21) on the stimulation of lymphocyte proliferation 
produced  by  allogeneic  cells.  Fig.  1  presents  the  results  of an  experiment 
comparing  the  effects of increasing  concentrations  of each  lipoprotein  on the 
unidirectional  mixed  lymphocyte  reaction  (MLR)  in  10%  type  AB  plasma. 
Addition of either LDL or VLDL markedly inhibited allogeneic cell stimulation. 
The LDL fraction produced the greatest inhibition,  with 50% inhibition occur- 
ring at 50 t~g LDL protein/ml,  and complete inhibition  of the MLR at 100 t~g! 
ml. The VLDL fraction also markedly inhibited the MLR, with 60% inhibition 
occurring  at  100  t~g VLDL protein/ml  and  almost complete inhibition  at  150 
tLg/ml.  HDL  also  strongly  inhibited  the  MLR,  but  only  at  much  higher 
concentrations.  In this experiment,  inhibition of the MLR was not observed at 
250 tLg HDL protein/ml,  but almost 90% inhibition was achieved at 500 t~g/ml. 
Similar results were obtained in two other experiments using the same classes 
of lipoproteins  from  two other  individuals  added  to  lymphocytes cultured  in 
type AB plasma,  and in another three experiments using a  completely autolo- 
gous system with the lipoproteins,  plasma,  and lymphocytes originating  from 
the same individual. 
Since the type AB and autologous plasmas utilized in the above experiments 
contained  lipoproteins,  it was decided to perform all of the remaining  experi- 
ments in LPDP, to eliminate the possibility of endogenous lipoproteins in the 
culture  medium contributing  to the effects of the  exogenously added  lipopro- 
teins.  Furthermore,  since  LDL  (d  =  1.006-1.063)  produced  the  strongest 
inhibition of the MLR (see above), it was decided to fractionate the d  --  1.006- 
1.063  lipoproteins  into  IDL  (d  =  1.006-1.019)  and  LDL  (d  =  1.019-1.063) 
fractions, and to study these separately in subsequent experiments. In addition, 
the lipoprotein fractions utilized in the subsequent experiments were generally 
prepared from a pooled plasma sample comprising plasma collected from three 
normal individuals,  to minimize the possibility of minor unrecognized individ- 
ual variations in lipoproteins with regard to their effects on cell proliferation. 
Fig.  2  shows  the  effects  of increasing  concentrations  of each  of the  four 
lipoprotein fractions  on the bidirectional  MLR, performed in  LPDP.  The IDL 
fraction  produced  the  most  marked  inhibition  of  lymphocyte  proliferation 
stimulated  by allogeneic cells,  with complete inhibition  being observed at  10 
t~g IDL protein/ml.  In fact, the incorporation of [~H]thymidine into DNA in the 
presence  of IDL  at  concentrations  of 10-250  tLg  protein/ml  was  suppressed 1794  EFFECTS  OF  LIPOPROTEINS  ON  LYMPHOCYTES 
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FIG.  1.  The  effects of lipoproteins on the  unidirectional MLR.  The  VLDL,  LDL  (d  = 
1.006-1.063),  and HDL fractions were all isolated from blood from one normal donor. Each 
0.25-ml culture mixture contained 2  x  l0  s stimulator and 2  ×  10  ~ responder lymphocyte~ 
in 10% heat-treated type AB plasma (Materials and Methods). Lipoprotein concentrations 
are expressed as micrograms of lipoprotein protein per milliliter of culture, and [3H]thymi- 
dine incorporation into DNA as the mean -+ 1 SEM of  triplicate cultures for each data point. 
The four control data points (m) represent the values seen without added lipoproteins, for 
the responder cells alone (RESP), the stimulator cells alone (before mitomycin treatment; 
STIM, and after; STIM +  MITOMYCIN) and for the mixed stimulator (mitomycin treated) 
+  responder cells (STIM  +  RESP). 
below  the  values  seen  for the  resting  controls  (unstimulated cells)  of both 
donors.  VLDL  and  LDL  were  both  strongly  inhibitory,  although  only  at 
singificantly higher concentrations than IDL. VLDL did not inhibit allogeneic 
cell stimulation when added at 1-10  ~g VLDL protein/ml. Approximately 80% 
inhibition occurred, however, at 50 ~g VLDL protein/ml, and complete inhibi- 
tion  at  100  ~g/ml.  LDL  produced  nearly  90%  inhibition  at  150  ~tg/ml  and 
suppression of [~H]thymidine uptake into DNA below that of resting controls 
between 300  and 500  ~g/ml.  HDL was not inhibitory at concentrations up to 
500  ~g/ml, but at 3,000  ~g HDL protein/ml, >90% inhibition was observed. 
Similar  findings  were  obtained  in  two  experiments  using  a  completely 
autologous  unidirectional  MLR,  with  lymphocytes, lipoproteins,  and  LPDP 
from the same individual, and also in another three experiments with bidirec- 
tional MLR using lipoproteins from pooled plasma and LPDP from pooled AB 
plasma.  In  all  of these  experiments,  the  relative  inhibitory potency of the 
different lipoprotein fractions was always found to be IDL >  VLDL >  LDL >> 
HDL,  and  inhibition  was  observed  at  lipoprotein  concentrations  similar  to 
those shown in Fig. 2. 
Effects  of Lipoproteins  on  Mitogen  Stimulation.  Experiments  were  also 
carried out to study the effects of lipoproteins on lectin-stimulated lymphocytes. 
Fig. 3 shows the effects of VLDL, IDL, LDL, and HDL, on PHA-P-stimulated 
lymphocytes cultured in LPDP.  Each of the lipoprotein fractions was able to JANE  H.  MORSE~  LARRY  D.  WITTED  AND  DEWITT  S.  GOODMAN 
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FIG.  2.  The effects of VLDL, IDL, LDL, and HDL on the bidirectional  MLR. Each 0.25- 
ml culture mixture contained 2 x 10  ~  cells from each donor in 25% LPDP. The lipoprotein 
fractions were isolated from pooled plasma from three individuals.  Lipoprotein concentra- 
tions are expressed  as  micrograms  of lipoprotein  protein per milliliter of culture and 
[3H]thymidine incorporation  into DNA as the mean -+ SEM of triplicate cultures for each 
data point.  The three control data points  (I) represent the values seen without added 
lipoproteins for the cells from each donor cultured alone (CELL CONTROLS 1 and 2) and 
for the cells cultured together (1 + 2). 
completely inhibit the mitogen-induced stimulation of lymphocyte proliferation. 
The rank order of inhibitory potency by the four lipoproteins was the same as 
that  seen with the  MLR.  Thus,  IDL was  the strongest inhibitor,  followed by 
VLDL, LDL, and finally HDL, which inhibited only at higher concentrations. 
IDL inhibited  lectin stimulation  >90%  at  10  ~g IDL protein/ml,  with almost 
complete inhibition observed at 20  ~g/ml.  VLDL produced ~75% inhibition at 
10  ~g  VLDL protein/ml  and  complete inhibition  at  50  ~g/ml.  LDL provided 
almost 90% inhibition at 50 ~g LDL protein/ml, with complete inhibition at 100 
~g/ml.  HDL was  not  inhibitory  at  100  ~g  HDL  protein/ml;  it  did,  however, 
produce  >50%  inhibition  at  250  ~g/ml,  almost  90%  inhibition  at  500  ~g/ml, 
and  complete  inhibition  at  3,000  ~g/ml.  As  with  the  MLR,  the  lipoproteins 
suppressed  [3H]thymidine  incorporation  into  DNA  below  that  of the  resting 
control  cultures  (no  PHA-P  added)  at  the  highest  lipoprotein  concentrations 
tested. 
Similar results were obtained in three other experiments with PHA-P. One 
experiment used a  completely autologous system of lymphocytes, lipoproteins, 
and autologous plasma,  and the other two experiments used lipoproteins from 
pooled plasma and LPDP from pooled AB plasma. 
Fig.  4 describes the effects of the same four lipoprotein fractions on lympho- 
cytes stimulated by another lectin,  Con A.  With minor variations,  the results 
were almost identical to those observed with PHA-P (see Fig.  3).  The relative 
potency  for  inhibition  of lectin-stimulated  lymphocyte proliferation was,  as 
before, IDL >  VLDL >  LDL >>  HDL. Moreover, as in the above experiments, 
the highest concentrations of all of the lipoproteins suppressed  [3H]thymidine 
incorporation into DNA below the level seen with the resting control cultures. 
Other  Studies.  HDL  preparations  isolated  by  a  single  ultracentrifugal 
flotation  between  densities  1.063  and  1.21  may  be  contaminated  with  small 1796  EFFECTS  OF  LIPOPROTEINS  ON  LYMPHOCYTES 
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FIG.  3.  The effects of VLDL,  IDL,  LDL,  and HDL  on PHA-P-stimulated lymphocytes. 
Each 0.25-ml culture mixture contained 2  x  105 lymphocytes in 25% LPDP.  PHA-P was 
used  at  a  concentration  of 5  #1  of the  pretested  stock  solution]ml  of culture.  Isolated 
lipoprotein fractions, obtained from pooled plasma from three individuals, are expressed 
as micrograms of lipoprotein protein per milliliter of culture. The data represent mean _+ 
SEM  values  for  [3H]thymidine  incorporation into  DNA  for  triplicate  cultures  for  each 
point. The two control data points (I) represent the values seen without added lipoprotein 
for the cells alone (CELL CONTROL) or the cells +  PHA-P. 
amounts  of  LDL.  The  question  was  therefore  raised  whether  or  not  the 
inhibitory effects of HDL, seen at relatively high concentrations in the above 
experiments (Figs.  1-4),  might be largely the result of the presence of small 
amounts of contaminating LDL.  To examine this question,  lipoproteins were 
prepared from normal plasma by sequential ultracentrifugal flotation at densi- 
ties  of  1.006,  1.019,  1.063,  1.085,  and  1.21.  The  HDL  preparation  isolated 
between  densities  of 1.085  and  1.21,  and  accordingly free of contaminating 
LDL,  was  then tested for its  effects on stimulated lymphocytes. Two experi- 
ments were conducted in which the effects of VLDL  (d  <  1.006),  LDL  (d  = 
1.019-1.063), and HDL (d =  1.085-1.21) were examined on: (a) the bidirectional 
MLR,  and  (b)  PHA-P-stimulated lymphocytes. The methods  employed were 
similar to those described above for the experiments shown in Figs. 2 and 3. In 
both experiments, the HDL (d =  1.085-1.21) inhibited stimulated lymphocytes 
in a  manner that was quantitatively similar to the inhibition previously seen 
with HDL (d  =  1.063-1.21).  In the lectin (PHA-P) experiment, the inhibitory 
effects seen at a given HDL concentration (d =  1.085-1.21) were quantitatively 
very similar  to  those  shown  for  HDL  in  Fig.  3.  In  the  bidirectional  MLR 
experiment, inhibitory effects were seen  at  HDL concentrations (d  =  1.085- 
1.21) somewhat lower than those which produced inhibition in the experiment 
shown in Fig.  2,  and more similar to the HDL concentrations which produced 
inhibition in the experiment shown in Fig.  1.  In these two experiments with 
HDL (d  =  1.085-1.21), moreover, the effects of VLDL and LDL were quantita- 
tively similar to those shown in Figs. 2 and 3. These experiments thus indicate 
that the inhibitory effects seen with HDL were not the result of the presence of 
small amounts of contaminating LDL. 
Although it has not been extensively studied, the inhibition of lymphoprolif- JANE  H.  MORSE,  LARRY  D.  WITTE,  AND  DEWITT  S.  GOODMAN  1797 
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FIo. 4.  The effects of VLDL, IDL, LDL, and HDL on Con A-stimulated lymphocytes. 
Each 0.25-ml culture mixture contained  2 x 105 lymphocytes  in 25% LPDP. The lipoprotein 
fractions were obtained, and the data are expressed, as described in the legend to Fig. 3. 
The two control data points (.) represent the values seen without added lipoprotein for 
the cells alone (CELL  CONTROL), or the cells + Con A. 
eration by normal plasma lipoproteins could also be documented by examining 
the numbers of lymphoblasts present as well as by [3H]thymidine incorporation. 
50%  inhibition  of  [3H]thymidine  incorporation  by  LDL  of  PHA-stimulated 
cultures also produced 50% inhibition of blast transformation when examined 
either  directly by  phase  microscopy or  by  light  microscope  examination of 
Wright's stained smears. 
Discussion 
The  results  presented  here  demonstrate that  all  of the  classes  of normal 
plasma  lipoproteins  can  strongly  inhibit  the  proliferation  of  ly_nphocytes 
stimulated by allogeneic cells or lectins. Inhibition was observed when lipopro- 
teins  were  added  to  lymphocytes cultured  in  autologous,  heterologous,  or 
LPDP. Generally similar degrees of inhibitory potency were observed with the 
different lipoproteins in all of the different experiments performed. In each of 
the  experiments  involving  the  four  different  lipoprotein  classes,  both  for 
allogeneic cell  and  lectin stimulation, and  for incubations containing whole 
plasma or LPDP, the rank order of inhibitory potency was always the same. 
Thus, in every instance, IDL was the strongest inhibitor, followed by VLDL, 
LDL,  and  HDL,  which  inhibited at  higher concentrations.  In  addition,  the 
concentration of a  given lipoprotein required for inhibition was  of a  similar 
order of magnitude in the various experiments involving both allogeneic cell 
and phytohemagglutinin  stimulation. Moreover, at relatively higher concentra- 
tions, the lipoproteins d  <  1.063 (VLDL, IDL, and LDL) consistently (and in 
the  case  of HDL,  often)  suppressed  the  incorporation of [3H]thymidine into 
DNA below the levels seen with resting, unstimulated control lymphocytes. 
The potential physiological significance of these observations is illustrated in 
Table  I,  which  summarizes  the  concentrations of each  lipoprotein  found to 
provide 50% and almost complete (>95%) inhibition of allogeneic cell stimula- 
tion: roughly similar concentrations of the lipoproteins also provided a similar 1798  EFFECTS  OF  LIPOPROTEINS  ON  LYMPHOCYTES 
TABLE I 
Lipoprotein  Concentrations for Inhibition of Allogeneic  Cell 
Stimulation, Compared to Normal Plasma Levels 
LP class  LP density 
Approximate LP levels to 
achieve inhibition of* 
50%  >95% 
Normal LP 
levels in 
plasma* 
VLDL  <1.006  2-4  8-12  10-20 
IDL  1.006-1.019  0.4-0.8  2-4  6-9 
LDL  1.019-1.063  5-10  15-30  50-80 
HDL  1.063-1.21  50-100  200-300  125-175 
* Lipoprotein  (LP)  levels  are  expressed  as  milligrams  of  LP  protein  per 
deciliter.  The  representative normal  plasma  levels listed were  estimated 
from the published values for normal levels of the plasma lipoproteins and 
lipoprotein lipids (11, 12). 
order of magnitude  of inhibition  of lectin  stimulation.  The  concentrations  of 
VLDL, IDL, and LDL required for complete inhibition of stimulated lymphocyte 
proliferation were all considerably below the levels of each of these lipoproteins 
normally  found  in  human  plasma.  In  addition,  the  concentration  of HDL 
required for 50-90% inhibition was in the range of HDL levels normally found 
in  human  plasma.  These  observations  suggest  that  circulating  lymphocytes 
may  normally  be  highly  suppressed  by  the  combined  effects  of all  of the 
different endogenous plasma  lipoproteins,  and that  lipoproteins  may,  accord- 
ingly,  play  important  roles  in  vivo in  modulating  lymphocyte functions  and 
responses. 
A  puzzling  but  unexplained  feature  of these  studies  derives  from the  fact 
that effective lymphocyte stimulation,  and lipoprotein inhibition of stimulated 
lymphocytes,  was  observed  when  lymphocytes  were  cultured  in  10%  whole 
plasma  (Fig.  1).  Significant  inhibition  of lymphocyte stimulation  might  have 
been anticipated in such experiments from the lipoproteins present in the 10% 
whole plasma.  The basis for the apparent  absence of such effects is not clear, 
and  will require  future  study.  It should be noted,  however,  that  most of the 
experiments reported here were conducted with LPDP to avoid this problem. 
The  inhibition  of stimulated  human  lymphocytes by VLDL  and  LDL  has 
been  observed  by  other  investigators  (2,  3),  although  the  effects  of these 
different lipoproteins were neither compared with each other, nor investigated 
in LPDP. Waddell et al.  (3) reported that plasma from patients with type IV or 
V  hyperlipoproteinemia  inhibited both spontaneous  and stimulated  (by mito- 
gens  and  antigens)  incorporation  of [3H]thymidine  by cultured  mononuclear 
cells.  The  inhibitory  effect was  identified  with  the  chylomicron  and  VLDL 
fractions  isolated from plasma.  Curtiss  and  Edgington  (2) reported that  LDL 
(d  =  1.006-1.063),  isolated  from  normal  human  serum  by  three  different 
methods (ultracentrifugal  flotation, affinity chromatography on Con A-Sepha- 
rose  4B,  and  polyanion  precipitation)  inhibited  both  mitogen  and  allogeneic 
cell-induced  lymphocyte  proliferation.  A  subfraction  of  LDL  (LDL-In)  was 
isolated and gave the greatest inhibition.  LDL-In had a  mean buoyant density 
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referred to as the T-lymphocyte, E-rosette inhibitory factor, previously studied 
by Chisari  and Edgington  (1). In more recent studies, intravenous injection of 
preparations  of  partially  purified  LDL-In  strongly  suppressed  the  in  vivo 
mouse anti-sheep  erythrocyte hemagglutination  response (16).  The activity of 
the  partially  purified  preparations  of LDL-In  studied  by these  investigators 
was reported  in terms  of the  amount  of lipoprotein  protein  required  for 50% 
inhibition of [3H]thymidine uptake by PHA-stimulated human peripheral blood 
lymphocytes (2,  16); this degree of inhibition was usually achieved with 10-20 
/~g LDL-In protein/ml. 
In  the  studies  reported  here,  50%  inhibition  of  [~H]thymidine  uptake  by 
PHA-stimulated lymphocytes was observed at IDL protein concentrations of 2- 
4  /~g/ml.  Thus,  IDL  appears  to  be  a  significantly  more  potent  inhibitor  of 
stimulated lymphoproliferation than the partially purified LDL-In preparations 
studied by Curtiss and colleagues (2,  16). Moreover, VLDL olden produced 50% 
inhibition of PHA-stimulated lymphocytes at concentrations of 5-10/~g protein/ 
ml (Fig. 3). These findings do not support the concept that there is a particular 
subspecies of LDL (i.e.,  LDL-In) that serves specifically as an immunoregula- 
tory lipoprotein (2, 16). The results suggest instead, that all normal lipoproteins 
of d  <  1.063,  and particularly the IDL fraction, have potent immunosuppressive 
activity, and that all normal lipoproteins (including HDL) may play important 
immunoregulatory roles in vivo. There is also the broader issue of whether the 
effects of lipoproteins  are restricted to lymphoid cells or whether lipoproteins 
might  also influence the  growth of other kinds of cells as well.  For example, 
Leffert  and  Weinstein  (17)  have  observed  inhibition  of  DNA  synthesis  of 
regenerating  liver cells by VLDL. 
The  studies  reported  here  did  not  explore  the  mechanism  of lipoprotein 
inhibition  of lymphoproliferation,  nor did they evaluate whether the lipopro- 
teins  interfered  with  lymphocytes, monocytes,  or  both.  Mechanistically,  it 
would be of interest to investigate whether or not the lipid or the apolipoprotein 
moiety of the lipoproteins are mainly responsible for the inhibition.  Apolipopro- 
tein B is common to all the lower density (d <  1.063) lipoproteins, representing 
the major apoprotein of LDL and also comprising  ~35% of VLDL protein  (12, 
18).  The  lower  density  lipoproteins  (d  <  1.063)  also  share  the  property  of 
interacting  strongly with polyanions and being readily precipitated by appro- 
priate combinations of polyanion (e.g., heparin or dextran sulfate) and divalent 
cation  (19,  20).  Future  studies  will  be required  to  explore  whether  these  or 
other  characteristics  of the  lipoproteins  might  be involved in  the  inhibitory 
phenomenon. 
The  experiments  involving  the  MLR  indicate  that  the  lipoproteins  must 
interact in some way with the cells in order to produce the observed inhibitory 
effects.  Waddell  et  al.  (3)  have  shown  that  [3H]thymidine  does  not  bind  to 
VLDL  and  chylomicrons,  and  there  is  no  reason  to  think  that  the  labeled 
nucleotide might bind to any of the other lipoproteins.  Lower density lipopro- 
teins are, however, known to interact with certain (but not all) lectins, such as 
Con  A  (21,  22).  The  possibility of significant  binding  of PHA to  VLDL  and 
chylomicrons was evaluated by Waddell et al.  (3) using ~25I-PHA. They found 
that  the  labeled  lectin  was  not  bound  to  the  lipoproteins  in  appreciable 1800  EFFECTS  OF  LIPOPROTEINS  ON  LYMPHOCYTES 
amounts. Curtiss and Edgington (2) also concluded that the possibility of LDL- 
In competing with cellular sites for lectin binding was unlikely. Most important, 
however, are the findings that the various lipoproteins strongly inhibited the 
MLR, since available data suggest that the cellular sites which bind Con A are 
not involved in the MLR (23). 
The  fact  that  lipoproteins  can  bind  to  lymphocytes  and  regulate  cellular 
processes has been demonstrated by the elegant studies of Brown and Goldstein 
and their  colleagues. These workers have shown that freshly isolated human 
lymphocytes (4) and long-term human lymphoid cell lines (24) have cell surface 
receptors  for  LDL  that  play  a  key role  in  the  regulation  of cholesterol  and 
lipoprotein metabolism by the cells in a  manner similar to that demonstrated 
in  fibroblasts  (25).  Thus,  it  is  possible that  lipoprotein  interaction  with  the 
lymphocyte surface might affect in some way the cell surface sites involved in 
the  MLR  or  in  lectin  stimulation,  and  that  this  in  turn  might  lead  to  the 
observed inhibition of lymphoproliferation. 
One mechanism whereby lipoproteins might alter cell membrane character- 
istics is in influencing the composition of the membranes.  Shinitzky and Inbar 
(26) have noted that lymphoma cells have decreased surface membrane choles- 
terol  levels  and  microviscosity,  compared  to  normal  lymphocytes.  Both  the 
membrane  microviscosity and cholesterol levels could be raised by incubation 
of lymphoma  cells with  lecithin-cholesterol  (hl)  liposomes.  More recently,  it 
has been reported that the mitogenic response of human peripheral lymphocytes 
to  lectins  can  be  decreased  by  brief  treatment  of the  cells  with  lecithin- 
cholesterol  liposomes  (27).  Lipids  have  also been  reported  to  affect immune 
functions in other systems.  Specific inhibition  of lectin  and/or  antigen-stimu- 
lated  lymphocytes by polyunsaturated  fatty acids  and  by prostaglandins  has 
been  reported  (28,  29),  and  lipids  are  known  to  depress  reticuloendothelial 
phagocytosis (30).  As cited previously, Curtiss et al.  (16) have shown suppres- 
sion of the  primary  antibody response to  a  thymic-dependent  antigen,  sheep 
erythrocytes, by a species of LDL. However, patients with familial hyperlipide- 
mia are not known to be clinically immunodeficient, and very little information 
is  available  pertaining  to  the  regulation  of other  parameters  of the  immune 
response by lipoproteins other than the inhibition of in vitro-stimulated lympho- 
cytes. 
There is a growing list of naturally occurring circulating immunosuppressive 
factors  which have  recently been reviewed by Cooperband et  al.  (31).  These 
substances are usually immunosuppressive at near physiologic concentrations, 
are  not  antigen-dependent,  inhibit  only  lymphoid  cells,  and  frequently  lack 
species specificity. Most are assayed by inhibition of lymphoproliferation.  The 
effects of the  best  characterized  factors  have,  however,  also been  examined 
with  regard  to  other  important  immune  parameters,  such  as  the  ability  to 
inhibit  T-dependent  and  T-independent  antibody  formation  in  vivo  and  in 
vitro, as well as prolongation of homografts. Among the best characterized are 
an  a-globulin  (32),  now called  a-immunoregulatory  globulin,  and  its peptide 
(33),  C-reactive protein (34),  the SAA serum factor associated with amyloidosis 
(35),  and a-fetoprotein (36).  Recently, plasmin cleavage of fibrinogen has been 
shown  to  produce  low  molecular  weight  degradation  products  capable  of 
immunosuppression  (37).  The  results  reported  here  suggest  that  all  of the JANE  H. MORSE,  LARRY  D.  WITTE,  AND  DEWITT  S. GOODMAN  1801 
classes  of normal  plasma  lipoproteins,  but  particularly those of d  <  1.063, 
should also be considered as another group of naturally occurring immunosup- 
pressive factors. 
Summary 
Lipoproteins, isolated by sequential flotation at densities 1.006, 1.019,  1.063, 
and  1.21,  were  examined  for  their  ability  to  inhibit  human  lymphocytes 
stimulated by allogeneic cells and by lectins (phytohemagglutinin-P and con- 
canavalin A).  All the classes of normal plasma lipoproteins inhibited lympho- 
proliferation when peripheral blood lymphocytes were cultured in autologous, 
heterologous,  or  lipoprotein-deficient plasma  (d  >  1.21). The  rank order  of 
inhibitory  potency  was  intermediate  density  lipoprotein  (IDL)  >  very  low 
density lipoproteins (VLDL) >  low density lipoproteins (LDL) >> high density 
lipoproteins (HDL), regardless of the mode of stimulation. The concentrations 
of IDL, VLDL, and LDL required for complete inhibition of stimulated lympho- 
proliferation were considerably below the levels of each of these lipoproteins 
normally  found  in  human  plasma.  In  addition,  the  concentration  of HDL 
required for 50-90%  inhibition was in the range of HDL levels normally found 
in human plasma.  Moreover, at relatively higher concentrations, lipoproteins 
suppressed the incorporation of [~H]thymidine into DNA below the levels seen 
with resting, unstimulated lymphocytes. The results suggest that circulating 
lymphocytes may normally be highly suppressed by the combined effects of all 
the endogenous lipoproteins  and that  the lipoproteins  may play important  roles 
in vivo  in modulating lymphocyte functions  and responses. 
The excellent  technical  assistance  of  Mrs. Miriam Fine is  gratefully  acknowledged. 
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